0001209191-21-028984.txt : 20210429 0001209191-21-028984.hdr.sgml : 20210429 20210429160330 ACCESSION NUMBER: 0001209191-21-028984 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210427 FILED AS OF DATE: 20210429 DATE AS OF CHANGE: 20210429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 21870381 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-27 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Patient Officer Common Stock 2021-04-27 4 M 0 3884 86.52 A 44017 D Common Stock 2021-04-27 4 S 0 2346 215.58 D 41671 D Common Stock 2021-04-27 4 S 0 1338 216.67 D 40333 D Common Stock 2021-04-27 4 S 0 200 217.69 D 40133 D Common Stock 882 I 401(k) Common Stock 7368 I Held in Trust Stock Option (Right to Buy) 86.52 2021-04-27 4 M 0 3884 0.00 D 2027-02-02 Common Stock 3884 0 D Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $215.58 (range $215.09 to $216.07). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $216.67 (range $216.19 to $217.18). Open market sales reported on this line occurred at a weighted average price of $217.69 (range $217.60 to $217.78). Fully vested. /s/ Sabrina Yohai, Attorney-in-Fact 2021-04-29